Erythema nodosum leprosum post-COVID-19 vaccination: endemic while pandemic.

Fachler, T; Olshtain-Pops, K; Horev, L

Fachler, T; Olshtain-Pops, K; Horev, L.

Fachler T; Department of Dermatology, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.
Olshtain-Pops K; Department of Infectious Diseases, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.
Horev L; Department of Dermatology, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.

J Eur Acad Dermatol Venereol ; 36(7): e505-e506, 2022 07.

Article in English | MEDLINE | ID: covidwho-1714222

Subject(s)

COVID-19; Erythema Nodosum; Leprosy, Lepromatous; Leprosy, Multibacillary; Panniculitis; COVID-19/epidemiology; COVID-19/prevention & control; COVID-19 Vaccines; Erythema Nodosum/epidemiology; Humans; Pandemics; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leprosy, Lepromatous / Panniculitis / Erythema Nodosum / Leprosy, Multibacillary / COVID-19 Type of study: Observational study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.18035

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google